SOLIGENIX, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10KSB
10KSB/A
10QSB
10QSB/A
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DEFR14A
DRS
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PREC14A
PREN14A
PRER14A
REGDEX
S-1
S-1/A
S-1MEF
S-2
S-2/A
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10KSB/A | — | 0000812796-97-000010 | May 12, 1997 | Dec 31, 1996 |
| 10KSB/A | — | 0000812796-97-000009 | May 8, 1997 | Dec 31, 1996 |
| PRE 14C | INFORMATION STATEMENT | 0000812796-97-000008 | May 6, 1997 | — |
| 10KSB | — | 0000812796-97-000007 | May 1, 1997 | Jan 31, 1997 |
| 8-K/A | CHANGE IN FISCAL YEAR | 0000812796-97-000006 | Mar 5, 1997 | Jan 31, 1997 |
| 8-K | CHANGE IN FISCAL YEAR | 0000812796-97-000005 | Feb 26, 1997 | Jan 31, 1997 |
| 8-K/A | — | 0000812796-97-000004 | Feb 21, 1997 | Jan 31, 1997 |
| 8-K/A | — | 0000812796-97-000003 | Feb 10, 1997 | Jan 31, 1997 |
| SC 13D/A | — | 0000812796-97-000002 | Feb 3, 1997 | — |
| 8-K | — | 0000812796-97-000001 | Jan 27, 1997 | Jan 31, 1997 |
| 10QSB | — | 0000812796-96-000005 | Dec 12, 1996 | Oct 31, 1996 |
| SC 13D/A | SCHEDULE 13D - AMENDMENT NO. 2 | 0000950172-96-000777 | Nov 18, 1996 | — |
| 10QSB/A | — | 0000812796-96-000003 | Oct 28, 1996 | Jul 31, 1996 |
| 10QSB | — | 0000812796-96-000002 | Sep 16, 1996 | Jul 31, 1996 |
| SC 13D/A | SCHEDULE 13D AMENDMENT NO. 1 | 0000950172-96-000393 | Jul 16, 1996 | — |
| PRER14A | IMMUNOTHERAPEUTICS, INC. PRER14A | 0000950168-96-001195 | Jul 2, 1996 | — |
| 3 | FORM 3 | 0000950136-96-000488 | Jun 25, 1996 | — |
| 3 | FORM 3 | 0000950136-96-000487 | Jun 25, 1996 | — |
| 3 | FORM 3 | 0000950136-96-000486 | Jun 25, 1996 | — |
| SC 13D | SCHEDULE 13D | 0000950136-96-000479 | Jun 25, 1996 | — |
| 3 | FORM 3 | 0000950136-96-000489 | Jun 25, 1996 | — |
| 3 | FORM 3 | 0000950136-96-000490 | Jun 25, 1996 | — |
| SC 13D | DOMINION RESOURCES INC. | 0000950168-96-001074 | Jun 17, 1996 | — |
| 10QSB | — | 0000812796-96-000001 | Jun 13, 1996 | Apr 30, 1996 |
| PRE 14A | IMMUNOTHERAPEUTICS, INC. PRE14A #43633.1 | 0000950168-96-000929 | May 23, 1996 | Jul 15, 1996 |
| 10KSB | IMMUNOTHERAPEUTICS, INC. #43219.1 | 0000950168-96-000717 | Apr 30, 1996 | Jan 31, 1996 |
| 10QSB | — | 0000812796-95-000006 | Nov 28, 1995 | Oct 31, 1995 |
| 10QSB/A | — | 0000812796-95-000005 | Oct 4, 1995 | Jul 31, 1995 |
| 10QSB | — | 0000812796-95-000004 | Aug 30, 1995 | Jul 31, 1995 |
| 10QSB | — | 0000812796-95-000003 | Aug 8, 1995 | Apr 30, 1995 |